LONDON (Reuters) - GlaxoSmithKline is investing 17.5 million euros ($23.5 million) in a new venture fund to invest in drugs for rare diseases, underscoring the growing role of big drugmakers in backing start-up companies. GSK and many of its rivals are becoming more active in funding early-stage companies, reflecting both a desire to tap into smart ideas from outside their own laboratories and a scarcity of finance from many traditional venture capital firms. ... More »
By Yasmeen Abutaleb WASHINGTON (Reuters) - Four in 10 U.S. adults are now caring for a sick or elderly family member as more people develop chronic illnesses and the population ages, a new study has found. "More health care is happening at home," said Susannah Fox, associate director of the Pew Research Center's Internet and American Life project and the study's lead author. "As more people are able to be saved by medical advances, their lives are being extended, but they're also being sent home medically fragile. It's caregivers who are the first line of defense. ... More »
LONDON (AP) — A mysterious new respiratory virus that originated in the Middle East spreads easily between people and appears more deadly than SARS, doctors reported Wednesday after investigating the biggest outbreak in Saudi Arabia. More »
LONDON (Reuters) - GlaxoSmithKline is investing 17.5 million euros ($23.5 million) in a new venture fund to invest in drugs for rare diseases, underscoring the growing role of big drugmakers in backing start-up companies. GSK and many of its rival... More »
BRUSSELS (Reuters) - EU antitrust regulators fined nine drugmakers a total of 146 million euros ($195.5 million) on Wednesday for blocking the supply of cheaper medicines on the market, with a penalty of 94 million euros imposed on Denmark's L... More »
By Ben Hirschler LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals. The comp... More »
By Axelle du Crest and Valerie Parent PARIS (Reuters) - French start-up company Ynsect has identified a cheap, nourishing and locally sourced alternative to soybeans as a vital source of protein in animal feed. The clue is in its name. Ynsect is n... More »
LONDON (Reuters) - Britain's Duchess of Cambridge, Kate Middleton, will give birth to the future heir to the British throne in the same hospital where the late Princess Diana gave birth to Princes William and Harry, royal sources said on Wedne... More »
By Jessica Toonkel NEW YORK (Reuters) - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter. No deal i... More »
LONDON (Reuters) - The Duchess of Cambridge, Kate Middleton, will give birth to the future heir to the British throne in the same hospital where the late Princess Diana gave birth to Princes William and Harry, royal sources said on Wednesday. The ... More »